Loading…
DaVita Inc. is projected to rise to $306.45 by 2027, a +28% move from its current price of $238.86. DVA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $236.35 | $238.97 | $241.62 | +0.05% |
| Aug 2 | $235.38 | $239.08 | $242.84 | +0.09% |
| Aug 3 | $234.66 | $239.19 | $243.81 | +0.14% |
| Aug 4 | $234.07 | $239.30 | $244.64 | +0.18% |
| Aug 5 | $233.57 | $239.41 | $245.40 | +0.23% |
| Aug 6 | $233.13 | $239.52 | $246.09 | +0.28% |
| Aug 7 | $232.73 | $239.63 | $246.74 | +0.32% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $232.73 | $239.63 | $246.74 | +0.32% |
| Week 2 | $230.67 | $240.41 | $250.55 | +0.65% |
| Week 3 | $229.28 | $241.18 | $253.70 | +0.97% |
| Week 4 | $228.23 | $241.96 | $256.52 | +1.30% |
| Week 5 | $227.39 | $242.74 | $259.13 | +1.63% |
| Week 6 | $226.71 | $243.53 | $261.59 | +1.95% |
| Week 7 | $226.14 | $244.31 | $263.95 | +2.28% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers, and it also offers outpatient, hospital inpatient, and home-based hemodialysis services, along with clinical laboratories that perform routine tests for dialysis and other ESRD-related needs.
DaVita also supplies management and administrative services to outpatient dialysis centers and offers integrated care and disease management programs, clinical research, physician services, and comprehensive kidney care services. It engages in the transplant software business as part of its broad healthcare offerings. The firm was formerly known as DaVita HealthCare Partners Inc.
and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
DaVita Inc. (DVA) is a healthcare company focused on kidney dialysis services in the United States, with centers across the country and a suite of related lab and care-management services. The stock trades with a current price of $239.46 and a market capitalization of $15.37B, reflecting its position in the healthcare services sector and its enterprise scale (rank 684).
The current price and market position provide a baseline for assessing the longer-term price outlook. The longer-term forecast depicts a bullish trajectory with substantial upside, highlighted by rising average prices in the years ahead, including a path to multi-year highs.
A major floor 39.5% below — a decisive break under it would weaken the trend.
The nearest floor, 13.0% below — buyers have tended to step in here.
Price is pressing into resistance (0.9% away) — a breakout level to watch.
A major ceiling 9.8% above — clearing it would confirm fresh momentum.
Key DVA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DVA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $238.21 | Buy | $238.33 | Buy |
| MA 10 | $236.57 | Buy | $236.65 | Buy |
| MA 20 | $234.86 | Buy | $232.41 | Buy |
| MA 50 | $215.95 | Buy | $216.52 | Buy |
| MA 100 | $187.78 | Buy | $195.09 | Buy |
| MA 200 | $156.07 | Buy | $172.85 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 65.35 | Neutral |
| Stoch RSI (14) | 28.51 | Neutral |
| CCI (20) | 116.63 | Buy |
| Williams %R (14) | -22.46 | Info |
| MACD (12,26,9) | -0.77 | Sell |
| ROC (12) | 2.78 | Buy |
| Bollinger %B (20,2) | 0.85 | Neutral |
| Stochastic %K (14) | 77.54 | Neutral |
| TRIX (15) | 0.49 | Buy |
| Awesome (5,34) | 12.29 | Buy |
| Ultimate (7,14,28) | 58.39 | Neutral |
| Momentum (10) | 4.85 | Buy |
| Aroon Osc (25) | 96.00 | Buy |
| Hull MA (9) | 240.63 | Sell |
| ADX (14) | 38.62 | Buy |
| ATR (14) | 2.52 | Info |
Technically, the near term shows bullish momentum with RSI(14) at 70 and a price structure supported by a 50-day simple moving average near $212.66 and a 200-day simple moving average near $153.84. The stock has a defined near-term support at $203.83 and resistance at $237.28, with a 30-day price range from $221.22 to $259.20. The current bullish sentiment aligns with a backdrop of positive momentum indicators, suggesting potential for continued strength in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $103.87 | $238.86 | $316.00 | 0% | Neutral | |
| $251.27 | $306.45 | $390.56 | +28% | Bullish | |
| $264.49 | $328.72 | $430.44 | +38% | Bullish | |
| $330.78 | $417.50 | $558.47 | +75% | Bullish | |
| $418.06 | $534.83 | $728.40 | +124% | Bullish | |
| $464.88 | $602.03 | $832.95 | +152% | Bullish | |
| $529.50 | $693.49 | $973.22 | +190% | Bullish | |
| $555.24 | $734.89 | $1,044.74 | +208% | Bullish | |
| $597.02 | $798.07 | $1,148.17 | +234% | Bullish | |
| $699.57 | $944.03 | $1,373.32 | +295% | Bullish | |
| $1,058.56 | $1,490.00 | $2,271.80 | +524% | Bullish | |
| $2,380.54 | $3,593.95 | $5,874.57 | +14.0x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $103.87 | $238.86 | $278.10 | +0.00% |
| August 2026 | $208.56 | $243.18 | $288.98 | +1.81% |
| September 2026 | $212.42 | $249.11 | $298.80 | +2.44% |
| October 2026 | $210.78 | $248.32 | $300.06 | -0.32% |
| November 2026 | $211.21 | $249.76 | $303.63 | +0.58% |
| December 2026 | $217.87 | $258.53 | $316.00 | +3.51% |
Click any year to see its month-by-month DVA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect DVA to range from $103.87 to $316.00 through 2026. The $238.86 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The DVA price prediction for 2027 points to an average of $306.45 (low $251.27, high $390.56) — a potential gain of +28% on today's $238.86. Buyers look set to stay in control over this stretch.
In 2028, DVA is projected to trade between $264.49 and $430.44, averaging $328.72 — a potential gain of +38% from today's $238.86. That is up +7% on the projected 2027 average. Momentum favours further upside here.
DaVita Inc.'s 2029 outlook centres on $417.50, within a $330.78 to $558.47 range. That is up +27% on the projected 2028 average. That marks a +75% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, DVA could reach as high as $728.40, with a base case around $534.83 and support toward $418.06 — roughly +124% from $238.86. Momentum favours further upside here.
Expect DVA to range from $464.88 to $832.95 through 2031. The $602.03 average target implies a +152% move from current prices. That is up +13% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The DVA price prediction for 2032 points to an average of $693.49 (low $529.50, high $973.22) — a potential gain of +190% on today's $238.86. Momentum favours further upside here.
In 2033, DVA is projected to trade between $555.24 and $1,044.74, averaging $734.89 — a potential gain of +208% from today's $238.86. That is up +6% on the projected 2032 average. Buyers look set to stay in control over this stretch.
DaVita Inc.'s 2034 outlook centres on $798.07, within a $597.02 to $1,148.17 range. That is up +9% on the projected 2033 average. That marks a +234% change versus current levels. Momentum favours further upside here.
By 2035, DVA could reach as high as $1,373.32, with a base case around $944.03 and support toward $699.57 — roughly +295% from $238.86. Buyers look set to stay in control over this stretch.
Expect DVA to range from $1,058.56 to $2,271.80 through 2040. The $1,490.00 average target implies a +524% move from current prices. That is up +58% on the projected 2035 average. Momentum favours further upside here.
The DVA price prediction for 2050 points to an average of $3,593.95 (low $2,380.54, high $5,874.57) — a potential gain of +14.0x on today's $238.86. Buyers look set to stay in control over this stretch.
Investing $1,000 in DVA today (≈ 4.186553 DVA) could be worth
$15,046.27
+$14,046.27 (+1405%) by 2050 · US Dollar
Based on the average projected DVA price of $3,593.95 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DVAwould be worth at today's price.
$1,000 invested in DVA on Jul 30, 2025 (≈ 6.917064 DVA) would be worth
$1,652.21
+$652.21 (+65.2%) today · 1.65× · US Dollar
Based on a DVA entry price of $144.57 vs. today's $238.86.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $234.27 | $1,019.59 | +2.0% |
| 1 month ago | $222.48 | $1,073.62 | +7.4% |
| 3 months ago | $151.65 | $1,575.07 | +57.5% |
| 6 months ago | $109.34 | $2,184.56 | +118.5% |
| 1 year ago | $144.57 | $1,652.21 | +65.2% |
| All time (5.0y) ago | $121.37 | $1,968.03 | +96.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DVA forecast.
Our base-case forecast reaches $480.00 around 2030.
Implied market cap at $480.00: $30.81B
The multi-year forecast shows a clear pathway of upside, with the average price rising across key milestones and strong bullish sentiment from 2027 onward. In 2030, the average forecast is $528.68 with a max of $720.09 and a minimum of $413.22, yielding an estimated ROI of 120.8% and bullish sentiment. By 2040, the average forecast climbs to $1,451.09 with a max of $2,212.59 and a min of $1,030.88, delivering an estimated ROI of 506% and continuing bullish momentum.
By 2050, the average forecast reaches $3,483.14 with a max of $5,693.63 and a min of $2,307.07, corresponding to an estimated ROI of 1,354.6% and a sustained bullish outlook. Across these years, the forecast reflects an uptrend in sentiment from neutral in 2026 to bullish in later years, with substantial upside potential indicated by the high-end forecasts. These figures are estimates, not guarantees, and actual results may vary.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $528.68, a high of $720.09, and a low of $413.22, with an estimated ROI of 120.8% and bullish sentiment.
Near term starts neutral in 2026 (avg $239.46, min $103.87, max $317.04, ROI 0, sentiment Neutral). From 2027 onward, the outlook becomes bullish with rising averages (e.g., 2027 avg $305.39, 2028 avg $327.09, 2029 avg $414.59) and improving ROIs (27.5% in 2027, 36.6% in 2028, 73.1% in 2029).
Yes. The 2040 forecast shows a maximum of $2,212.59, with an average of $1,451.09 and a minimum of $1,030.88, delivering a 506% ROI and bullish sentiment.
Current price is $239.46 and market cap is $15.37B, with a rank of 684.
The long-term forecast suggests substantial upside, with 2030, 2040, and 2050 showing increasingly higher average prices and very large ROIs (120.8%, 506%, and 1,354.6% respectively) and bullish sentiment. These are estimates, not guarantees, and actual results can vary.
DaVita Inc. Community Discussion
0Share your DaVita Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.